CLINICAL_TRIALS
trial_result
· 2018-05-16
Clinical Trial Update: A Study of Evacetrapib in High-Risk Vascular Disease [Phase 3]
Summary
Phase 3 trial of evacetrapib in high-risk vascular disease was terminated with results posted in 2018.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Eli Lilly and Company | Conditions: Cardiovascular Diseases | Phase 3 | Status: TERMINATED | Results posted: 2018-05-16